Kerry Jardine's law practice focuses on representing clients who have suffered catastrophic personal injuries and losses. Mr. Jardine's practice consists of securities arbitration, catastrophic injury cases, wrongful termination actions, and mass torts including pharmaceutical class actions, such as Fen-Phen, Rezulin, Propulsid, and PPA (phenylpropanolamine), and commercial litigation. Mr. Jardine's clients have received successful verdicts and settlements in his areas of expertise exceeding $40 million. Kerry Jardine has been selected by members of the national legal community for inclusion in the 2008 and the 2009 Best Lawyers in America in the speciality of Mass Tort Litigation. Best Lawyers publishes a book each year listing those individuals who are chosen by confidential evaluations and telephone interviews conducted with other attorneys across the country. The book is considered to be, professionally, the definitive guide to legal excellence in the United States. Mr. Jardine was chosen as a member of this distinguished group because he has displayed an exemplary commitment to his profession, his community and to his clients. Mr. Jardine has also met the standard of excellence for selection as one of the American Trial Lawyers Association's Top 100 Trial Lawyers.